Sleep disorder and Affect lability

Summary:

Affect lability is found among people with Sleep disorder, especially for people who are female, 30-39 old.

The study analyzes which people have Affect lability with Sleep disorder. It is created by eHealthMe based on reports of 113 people who have Sleep disorder from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Sleep disorder?

Sleep disorder is found to be associated with 2,103 drugs and 2,938 conditions by eHealthMe. Check the latest studies of Sleep disorder.

What is Affect lability?

Affect lability (emotional incontinence) is found to be associated with 669 drugs and 828 conditions by eHealthMe. Check the latest studies of Affect lability.

On Jul, 16, 2026

113 people who have Sleep Disorder and Affect Lability are studied.

Would you have Affect lability when you have Sleep disorder?

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Affect lability?

- Check whether Affect lability is associated with a drug or a condition

Related publications that referenced our studies

Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .
Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .

Related studies:

Treatments, associated drugs and conditions:

Sleep disorder (167,338 reports)
Affect lability (13,491 reports)

All the drugs that are associated with Affect lability:

Affect lability (669 drugs)

All the conditions that are associated with Affect lability:

Affect lability (828 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Affect lability and Sleep disorder, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.